Related Experiment Video
Updated: Jan 21, 2026

Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis
Published on: January 2, 2017
Morphine contributed to the deterioration of cancer via miR-543/MARCKS/FcγR-mediated phagocytosis pathway
Jianghui Luo1, Yiding Chen1, Yiquan Xu1
1Department of Anesthesiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Objectives:
It has been confirmed that morphine was detrimental to patients with cancers. Hence, we aimed to reveal a certain mechanism of morphine in cancer development.
Methods:
Microarray and GSEA analysis were utilized to seek for differently expressed genes and pathway.
Key Findings:
Bioinformatics analysis identified that downregulation of MARCKS and upregulation of miR-543 in samples treated with morphine. FcγR-mediated phagocytosis pathway was illustrated to be upregulated in the control. PANC-1 and DU145 cell viability was increased but apoptosis was declined as morphine concentration went up from 10-8 to 10-6 mol/l. On the other curve, the viability was reduced and apoptosis was elevated from 10-6 to 10-5 mol/l. The expression of miR-543 ran the same trend as cell viability. Assays in vivo and in vitro validated that miR-543 facilitated cell viability, tumour growth, levels of CA199 and PSA, whereas inhibited apoptosis. MARCKS could target and inhibit miR-543 expression, which exhibited an opposite effect on cancer progression. MiR-543 blocked but MARCKS activated FcγR-mediated phagocytosis pathway.
Conclusions:
Morphine at 10-6 mol/l could benefit miR-543 expression to inhibit MARCKS expression, consequently, blocking FcγR-mediated phagocytosis pathway, which contributed to the cancer progression in vitro and in vivo.
Insights
Morphine influences cancer progression by altering microRNA-543 (miR-543) and MARCKS expression. This modulation affects cell viability, apoptosis, and FcγR-mediated phagocytosis, impacting tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Morphine is known to negatively impact cancer patients.
- Understanding the precise mechanisms of morphine's effect on cancer is crucial.
Purpose of the Study:
- To elucidate the molecular mechanisms by which morphine influences cancer development.
- To investigate the roles of MARCKS and miR-543 in morphine-induced cancer progression.
Main Methods:
- Microarray and Gene Set Enrichment Analysis (GSEA) were employed to identify differentially expressed genes and pathways.
- In vitro and in vivo assays were conducted to validate findings.
Main Results:
- Morphine treatment led to decreased MARCKS and increased miR-543 expression.
- MiR-543 promoted cell viability and tumor growth while inhibiting apoptosis.
- MARCKS counteracted miR-543's effects and activated FcγR-mediated phagocytosis.
Conclusions:
- Morphine at 10⁻⁶ mol/l upregulates miR-543, downregulates MARCKS, and inhibits FcγR-mediated phagocytosis.
- This pathway contributes to cancer progression in vitro and in vivo.
- Targeting this pathway may offer therapeutic strategies for cancer patients using morphine.
Related Concept Videos
Phagocytosis
Phagocytosis
The objective of phagocytosis is often destruction. Cells use phagocytosis to eliminate unwelcome visitors, like pathogens (e.g., viruses and bacteria). Many immune system cells,...
Mortar Joint Deterioration in Masonry
The...
Opioid Analgesics: Morphine and Other Natural Cogeners
Binet's Contribution to Measures of Intelligence
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

